Term
|
Definition
non-selective NSAID
Low dose: analgesic, antipyretic
High dose: anti-inflammitory
Acetylation and inhibition of COX 1 and 2 is irreversible
Adverse effects
GI tract (due to COX-1 inhibition)
GI irritation -inhibition of cytoprotective PG's - PGE2, PGI2
Platelet inhibition
Hepatic and renal toxicity
Hypersensitivity - pruritis (itching)
Tinnitus - altered hearing at toxic doses
Reye's Syndrome: encephalopathy (brain disorder) |
|
|
Term
|
Definition
Analgesic and anti-pyretic effects
No anti-inflammitory activity
No GI tract irritation
Adverse effects
Hepatotoxicity at high doses
Metabolism by cytochrome P450 2E1 |
|
|
Term
|
Definition
Non-selective NSAID
GI and renal adverse effects limit use |
|
|
Term
|
Definition
Non-selective NSAID
Possibly associated with greatest toxicity overall
used in the acute treatment of Gout |
|
|
Term
|
Definition
Non-selective NSAID
One of the least toxic |
|
|
Term
|
Definition
Non-selective NSAID
associated with increased liver function abnormalities |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
COX-2 specific NSAID
Safest for patients with high risk for GI bleeding
May have increased risk of CV toxicity
very expensive |
|
|
Term
|
Definition
Acute treatment of Gout
Not first line anymore
Produces anti-inflammitory effect by inhibiting leukocyte migration and phagocytosis (via inhibition of microtubule aggregation) |
|
|
Term
|
Definition
Xanthine oxidase inhibitor
Blocks conversion of xanthine to uric acid
standard agent for periods between acute attacks of Gout |
|
|
Term
|
Definition
Xanthine oxidase inhibitor
Blocks conversion of xanthine to uric acid
More selective than Allopurinol |
|
|
Term
|
Definition
Uricosuric drug
Promotes uric acid renal excretion - increases renal clearance by inhibiting tubular absorption
Decreases the body pool of urate
GI and kidney stone side effects may limit use |
|
|
Term
|
Definition
Uricosuric drug
Promotes uric acid renal excretion - increases renal clearance by inhibiting tubular absorption
Decreases the body pool of urate
GI and kidney stone side effects may limit use |
|
|
Term
|
Definition
DMARD
First line treatment of RA
Inhibits AICAR transformylase |
|
|
Term
|
Definition
DMAR
Polypeptide antibiotic
Inhibits interleukin-1 and interleukin-2 receptor production- interferes with cytokine signaling |
|
|
Term
|
Definition
DMARD
Cytostatic cross-link DNA to prevent cell replication |
|
|
Term
|
Definition
DMARD
Interferes with nucleic acid metabolism and synthesis and inhibits cell proliferation
Suppresses B cell and T call function, immunoglobulin production and interleukin-2 secretion |
|
|
Term
|
Definition
DMARD
Inhibits ribonucleotide synthesis and causes cell cycle arrest
First agent for RA indicated for both symptomatic improvement and retardation of strucutral joint damage |
|
|
Term
|
Definition
DMARD
Anti-malarial agent
anti-inflammatory action in RA is unclear |
|
|
Term
|
Definition
DMARD
Anti-malarial agent
anti-inflammatory action in RA is unclear |
|
|
Term
|
Definition
DMARD
Gold compound
Alters the morphology and functional capabilities of human macrophages
Not used much anymore |
|
|
Term
|
Definition
DMARD
Gold compound
Alters the morphology and functional capabilities of human macrophages
Not used much anymore |
|
|
Term
|
Definition
DMARD
IgA and IgM rheumatoid factor production is decreased |
|
|
Term
|
Definition
Biologic DMARD
Anti-TNF agent
|
|
|
Term
|
Definition
Biologic DMARD
anti-TNF agent |
|
|
Term
|
Definition
Biologic DMARD
anti-TNF agent |
|
|
Term
|
Definition
Biologic DMARD
B-cell depleting agent |
|
|
Term
|
Definition
Biologic DMARD
T-cell costimulation inhibitor |
|
|
Term
|
Definition
Biologic DMARD
IL-1 inhibitor |
|
|
Term
|
Definition
Acute migraine drug
Vasoconstriction due to stimulation of alpha-adrenergic and 5-HT receptors |
|
|
Term
|
Definition
Acute migraine drug
Vasocontriction due to stimulation of alpha-adrenergic and 5-HT receptors
ergotamine + caffeine - facilitates absorption of ergotamine |
|
|
Term
|
Definition
Acute migraine drug
Selective 5-HT1D and 5-HT1B receptor agonists |
|
|
Term
|
Definition
Acute migraine drug
Selective 5-HT1D and 5-HT1B receptor agonists |
|
|
Term
|
Definition
Narrow spectrum penicillin
DOC for streptococci, meningococci, enterococci, penicillin-susceptible pneumococci and non-beta-lactamase producing staphylococci
IV |
|
|
Term
|
Definition
Narrow spectrum penicillin
indicated only in minor infections (poor bioavalibility, 4X day dosing and narrow spectrum of activity)
PO |
|
|
Term
|
Definition
Antistaphylococcal penicillin
treats serious beta-lactamase producing staph infections (acute endocarditis and osteomyelitis)
Staph that are resistant to these penicillins are MRSA |
|
|
Term
|
Definition
Extended spectrum penicillin
greater activity against gram - bacteria
treats UTIs, sinusitis, otitis and lower resp. tract infections
often combined with beta-lactamase inhibitors |
|
|
Term
|
Definition
Extended spectrum penicillin
greater activity against gram - bacteria
treats UTIs, sinusitis, otitis and lower resp. tract infections
often combined with beta-lactamase inhibitors
often combined with gentamicin for the treatment of serious infections (enterococcal endocarditis) |
|
|
Term
|
Definition
Antipseudomonal penicillin
active against gram negative rods and gram +
susceptible to beta-lactamases |
|
|
Term
|
Definition
Antipseudomonal penicillin
active against gram negative rods and gram +
susceptible to beta lactamases
more effective against P. auroginosa then ticarcillin |
|
|
Term
|
Definition
First generation cephalosporin
does not cross BBB |
|
|
Term
|
Definition
First generation cephalosporin
Does not cross BBB
DOC for surgical prophylaxis and an alternative to penicillin in pts with allergies |
|
|
Term
|
Definition
Second generation cephalosporin |
|
|
Term
|
Definition
Second generation cephalosporin
treatment for CA pneumonia
only 2nd generation that crosses BBB |
|
|
Term
|
Definition
Third generation cephalosporin
less susceptible to beta-lactamases and can cross the BBB
use can lead to psuedomembranous colitis (C.dif)
used in combo with aminoglycoside to treat meningitis from P. aeruginosa
active against N. gonorrhea |
|
|
Term
|
Definition
Third generation cephalosporin
less susceptible to beta-lactamases and can cross the BBB
use can lead to psuedomembranous colitis (C.dif)
used in combo with aminoglycoside to treat meningitis from P. aeruginosa |
|
|
Term
|
Definition
Fourth genration cephalosporin
more resistant to hydrolysis via beta-lactamases
Highly active against H. influenzae and N. Gonorrhea
Has the gram + coverage of a 1st generation and the gram - coverage of a 3rd generation |
|
|
Term
|
Definition
Beta-Lactamase inhibitor
very weak antibacterial activity
only available in fixed combos with specific penicillins |
|
|
Term
|
Definition
Beta-Lactamase inhibitor
very weak antibacterial activity
only available in fixed combos with specific penicillins |
|
|
Term
|
Definition
Beta-Lactamase inhibitor
very weak antibacterial activity
only available in fixed combos with specific penicillins |
|
|
Term
|
Definition
Monobactam
effective against gram negative bacilli
Penicillin allergic patients tolerate it without rxn
Side effect: bone marow suppression-induced leukopenia |
|
|
Term
|
Definition
Carbapenem
wide spectrum with good activity against gram +, gram - rods and anaerobes
activated by dehydropeptidases in the renal tubules
|
|
|
Term
|
Definition
|
|
Term
|
Definition
Bacterial cell wall synthesis inhibitor
active against gram + cocci and bacilli
inhibits cell wall synthesis by interfering with elongation of the peptidoglycan backbone and cross-linking |
|
|
Term
|
Definition
Bacterial cell wall synthesis inhibitor
inhibits early stage of cell wall formation
MOR - due to decreased transport of drug into bacteria
gram + and gram - organisms
Mainly used for UTIs |
|
|
Term
|
Definition
Bacterial cell wall synthesis inhibitor
blocks regeneration of bactoprenol, a lipid carrier molecule that transfers PG subunits to the growing cell wall
active aginst gram + cocci
limited to topical use - too nephrotoxic for systemic use |
|
|
Term
|
Definition
Bacterial cell wall synthesis inhibitor
inhibits the incorporation of D-alanine into peptidoglycan pentapeptide
primarily used to treat multidrug resistant TB
mycobacteria and gram -
side effects - psychosis, sedation, confusion, vertigo |
|
|
Term
|
Definition
Aminoglycoside
binds to the 30S subunit - blocks protein synthesis
Enzymatic modification is the most common MOR
Renal, vestibular and neuromuscular toxicities |
|
|
Term
|
Definition
Aminoglycoside
binds to the 30S subunit - blocks protein synthesis
Enzymatic modification is the most common MOR
Renal, vestibular and neuromuscular toxicities |
|
|
Term
|
Definition
Aminoglycoside
binds to the 30S subunit - blocks protein synthesis
Enzymatic modification is the most common MOR
Renal, vestibular and neuromuscular toxicities |
|
|
Term
|
Definition
Aminoglycoside
binds to the 30S subunit - blocks protein synthesis
Enzymatic modification is the most common MOR
Renal, vestibular and neuromuscular toxicities |
|
|
Term
|
Definition
Aminoglycoside
binds to the 30S subunit - blocks protein synthesis
Enzymatic modification is the most common MOR
Renal, vestibular and neuromuscular toxicities |
|
|
Term
|
Definition
Tetracycline
blocks 30S subunit by binding tRNA to the A site
Broad spectrum and bacteriostatic
MOR - bacteria gain efflux pumps by conjugation
DOC for Rocky Mountain Spotted Fever and other Rickettsia infections
DOC for borrelia induced lyme disease and relapsing fever
May cause discoloration of the teeth and hypoplasia of the enamel in children under 8
Can cause phototoxicity |
|
|
Term
|
Definition
Tetracycline
blocks 30S subunit by binding tRNA to the A site
Broad spectrum and bacteriostatic
MOR - bacteria gain efflux pumps by conjugation
DOC for Rocky Mountain Spotted Fever and other Rickettsia infections
DOC for borrelia induced lyme disease and relapsing fever
May cause discoloration of the teeth and hypoplasia of the enamel in children under 8
Can cause phototoxicity |
|
|
Term
|
Definition
Tetracycline
blocks 30S subunit by binding tRNA to the A site
Broad spectrum and bacteriostatic
MOR - bacteria gain efflux pumps by conjugation
DOC for Rocky Mountain Spotted Fever and other Rickettsia infections
DOC for borrelia induced lyme disease and relapsing fever
May cause discoloration of the teeth and hypoplasia of the enamel in children under 8
Can cause phototoxicity |
|
|
Term
|
Definition
Macrolide
block 50S subunit by blocking peptidyl transferase
MOR - efflux of drug out of bacteria and mutations in 50S subunit that decrease drug binding
Potent inhibitor of P450s - drug interaction alert |
|
|
Term
|
Definition
Macrolide
Affects the 50S ribosomal subunit
Blocks peptidyl transferase (translocation step) |
|
|
Term
|
Definition
Macrolide
Affects the 50S ribosomal subunit
Blocks peptidyl transferase (translocation step) |
|
|
Term
|
Definition
Macrolide
Affects the 50S ribosomal subunit
Blocks peptidyl transferase (translocation step) |
|
|
Term
|
Definition
blocks peptidyl transferase
broad spectrum antibiotic
readily crosses the BBB - good for treating meningitis
can induce fatal bone marrow suppression - this restricts its use to a few life-threatening infections
MOR - mutations in ribosome binding site, mutations in porins decrease influx, plasmids encode for enzymes that degrade antibiotic
Can cause Idiosyncratic aplestic anemia and Gray baby syndrome at high levels |
|
|
Term
|
Definition
Streptogramin
Inhibits protein synthesis
used for vancomycin resistant enterococcus
very expensive |
|
|
Term
|
Definition
Streptogramin
Inhibits protein synthesis
used for vancomycin resistant enterococcus
very expensive |
|
|
Term
|
Definition
Oxazolidinone
binds to the P site of the 50S subunit
Gram + organisms |
|
|
Term
|
Definition
Sulfonamide
inhibit folate synthesis
used for burn infections
broad spectrum
do not administer to pregnant women or newborns
used as an antiparasitic drug |
|
|
Term
|
Definition
Sulfonamide
blocks the synthesis of dihydrofolate
used for occular infections and trachoma
broad spectrum
do not administer to pregnant women or newborns |
|
|
Term
|
Definition
Inhibits Dihydrofolate reductase (DHFR)
MOR - plasmid encodes resistant DHFR, mutation in DHFR, overexpression of DHFR
used for bacterial prostatitis and vaginitis
often used in combo with sulfamethoxazole |
|
|
Term
|
Definition
first generation Quinolone
DNA gyrase inhibitor
bacteriostatic (but if bacteria cannot repair the damage can be bacteriacidal)
MOR - DNA gyrase mutation, porin mutation, increased efflux - note: no plasmid mediated resistance
limited gram - activity : UTIs only
do not prescribe to children and pregnant women |
|
|
Term
|
Definition
second generation Quinolone
DNA gyrase inhibitor
bacteriostatic (but if bacteria cannot repair the damage can be bacteriacidal)
MOR - DNA gyrase mutation, porin mutation, increased efflux - note: no plasmid mediated resistance
do not prescribe to children and pregnant women |
|
|
Term
|
Definition
third generation Quinolone
DNA gyrase inhibitor
bacteriostatic (but if bacteria cannot repair the damage can be bacteriacidal)
MOR - DNA gyrase mutation, porin mutation, increased efflux - note: no plasmid mediated resistance
do not prescribe to children and pregnant women |
|
|
Term
|
Definition
Behaves as a free radical to disrupt replication, transcription and DNA repair
Indicated for C. diff, H. pylori and D. medinensis
Used prophylactically for surgical procedures
antiparasitic
activated under anaerobic conditions by PFOR
disulfiram like effect - avoid alcohol consumption
Trichomoniasis - sexual partners should be treated simultaneously
Giardiasis - 90% success rate
Amebiasis - DOC for treating symptomatic DZ |
|
|
Term
|
Definition
Cyclic lipopeptide
disrupts membrane function in gram + organisms |
|
|
Term
|
Definition
blocks the formation of isoleucine-tRNAs
most staph and strep strains incuding MRSA |
|
|
Term
|
Definition
inhibits DNA dependent RNA polymerase
MOR - mutations in RNA polymerase
indicated for meningococcal carriers |
|
|
Term
|
Definition
used for prophylaxis and treatment of UTIs
can cause GI problems |
|
|
Term
|
Definition
disrupts cell membrane integrity
often used in creams or ointments
too nephrotoxic to give parenterally |
|
|
Term
|
Definition
Antiparasitic
effective at eliminationg E. histolytica from intestines
mild or asymptomatic cases of amebiasis |
|
|
Term
|
Definition
aminoglycoside antibiotic - inhibits protein synthesis
effective at eliminating E. histolytica from intestine
used to treat asymptomatic or mild cases of amebiasis |
|
|
Term
|
Definition
Interference with PFOR
treatment of Cryptosporidiosis and Giardiasis in individuals over 1 year of age |
|
|
Term
|
Definition
Antiparasitic drug
Inhibits DHFR |
|
|
Term
|
Definition
Antimalarial
half life in the body of 4 days
eliminates asexual erythrocytic stages of all species of plasmodium
BIG TIME resistance
|
|
|
Term
|
Definition
Antimalarial drug
poorest therapeutic:toxic ratio of all antimalarial drugs - cinchonism and hypoglycemia
eliminates asexual erythrocytic stages of all species of plasmodium |
|
|
Term
|
Definition
Antimalarial drug
some reports demonstrate severe neuropsychiatric rxns in .5% of patients
Effective against all species of plasmodium |
|
|
Term
|
Definition
Antimalarial drug
only drug that has activity against the liver (hypozoite) forms of P. vivax and P. ovale
patients should be screened for G6PD - RBC lysis |
|
|
Term
|
Definition
Antimalarial drug
treatment of P. falciparum malaria |
|
|
Term
|
Definition
Antimalarial drug - tetracycline
inhibits growth of plasmodium by disrupting protein synthesis
major side effects - photosensitivity dermatitis and staining of teeth in children - contraindicated in children and pregnant women |
|
|
Term
|
Definition
Antihelminthic - Benzimidazole
ascariasis, pinworm, hookworm and whipworm infections |
|
|
Term
|
Definition
Antihelminthic - Benzimidazole
ascariasis, pinworm, hookworm and whipworm infections |
|
|
Term
|
Definition
Antihelminthic - Benzimidazoles
second line drug used in the treatment of strongyloidiasis
used topically to treat cutaneous larval migrans |
|
|
Term
|
Definition
Antihelminthic
causes hyperpolarization in muscle cells - paralysis
no affect on mammalian cells
DOC for treating strongyloidiasis |
|
|
Term
|
Definition
Antihelminthic
activates cholinergic nicotinic receptors in nematodes - depolarizing neuromuscular blockade
no effect on humans
DOC for treating pinworms
TREATMENT OF THE ENTIRE HOUSEHOLD IS RECOMMENDED |
|
|
Term
|
Definition
Tapeworm and Fluke infection
Increase calcium permeability of the worm's tegument
Flukes : 3 doses in a single day
Tapeworms : a single dose
Cysticercosis : two weeks treatment |
|
|
Term
|
Definition
Polyene antifungal
Affinity for ergosterol sites - disrupt internal environment
Main toxicity is renal
Resistance is rare and slow to develop |
|
|
Term
|
Definition
Antifungal
Block the production of ergosteol by inhibiting a demethylation step
Significant inhibition of human CYP450 - drug interactions
Liver toxicity
|
|
|
Term
|
Definition
Antifungal
Block the production of ergosteol by inhibiting a demethylation step
Significant inhibition of human CYP450 - drug interactions
Liver toxicity |
|
|
Term
|
Definition
Antifungal
Block the production of ergosteol by inhibiting a demethylation step
Significant inhibition of human CYP450 - drug interactions
Liver toxicity |
|
|
Term
|
Definition
Antifungal
Inhibition of cell wall synthesis - block production of chitin
indicated for inavasive aspergillosis when other therapy fails |
|
|
Term
|
Definition
Antifungal
Inhibition of cell wall synthesis - block production of chitin
indicated for inavasive aspergillosis when other therapy fails |
|
|
Term
|
Definition
Antifungal
Inhibition of nucleic acid synthesis (ultimately thymidylate synthase) |
|
|
Term
|
Definition
Antifungal
Squalene epoxidase inhibitor
superficial infections |
|
|
Term
|
Definition
Antifungal
binds to tubulin to inhibit mitosis
deposited in nails
for superficial infections, but not used as much as Terbinafine |
|
|
Term
|
Definition
Antimycobacterial
DOC for the chemotherapy of TB
Inhibits biosynthesis of mycolic acid
Bacteriostatic for resting bacilli
Bacteriocidal for dividing bacilli
specifically activated by catalase-peroxidase
Extensively metabolized by hepatic acetyltransferase
drug induced hepatitis - rapid acetylators
peripheral neuritis, SLE like symptoms - slow acetylators |
|
|
Term
|
Definition
Antimycobacterial
inhibits RNA polymerase of bacilli
hepatic activation
broad spectrum
used prophylactically in pts with isoniazid resistance
most used with isoniazid for treatment of TB
Hypersensitivity rxn in 50% of pts
potential hepatitis
discoloration of body fluids |
|
|
Term
|
Definition
Antimycobacterial
used to treat M. avium intracellulare infections
HIV+ pts
|
|
|
Term
|
Definition
Antimycobacterial
M. tuberculosis or M. avium
used in resistant and HIV+ patients
May alter vision (color discrimination) |
|
|
Term
|
Definition
Antimycobacterial
good for active TB infection
inhibits fatty acid synthetase I
must be used in combo therapy with other drugs |
|
|
Term
|
Definition
antimycobacterial
first drug used to treat TB
not used much, only when resistant to other drugs |
|
|
Term
|
Definition
Antimycobacterial
sulfone
bacteriostatic inhibition of folic acid synthesis in M. leprae |
|
|
Term
|
Definition
antimycobacterial
bacteriostatic activity against M. leprae and MAC
anti-inflammatory and immunologic activity
erythema nodosum leprosum (skin lesions)
highly lipophilic - long half life
skin and body fluid discoloration |
|
|
Term
|
Definition
Antimycobacterial
alleviates the presentation of erythema nodosum leprosum
Teratogenic - babies born with missing limbs (phocomelia) |
|
|
Term
|
Definition
Antiviral
Parkinson's - blocks nicotinic cholinergic receptor
viral infections - binds M2 membrane protein
Not active against influenza B
accelerates recover from fever if administered within 48 hours of exposure
prophylacically to protect children and elderly from flu |
|
|
Term
|
Definition
antiviral
inhibits neuraminidase of influenza A and B virus
reduce the length of illness |
|
|
Term
|
Definition
antiviral
inhibits neuraminidase of influenza A and B virus
reduce the length of illness |
|
|
Term
|
Definition
antiviral
prodrug - activated by herpesvirus thymidine kinase (binds to TK very specifically)
inhibits DNA replication
used for HSV-1 and VZV (chicken pox) |
|
|
Term
|
Definition
antiviral
prodrug - activated by viral phosphorylation
potent vs. HSV and CMV
low margin of safety - granulocytopenia and thrombocytopenia
teratogenic and embryotoxic |
|
|
Term
|
Definition
antiviral
CMV, HSV-1 and 2 and VZV
IV administration only
CMV retinitis pts with AIDS and acyclovir resistant HSV infections in immunocompromised pts |
|
|
Term
|
Definition
antiviral
nucleoside analog of thymidine and adenosine
inhibit viral DNA synthesis
limited to topical treatment of HSV and HPV |
|
|
Term
|
Definition
antiviral
nasal aerosol for RSV
prodrug that must be phosphorylated
disrupts purine metabolism - viral DNA synthesis inhibited
contraindicated in pregnancy and lactation |
|
|
Term
|
Definition
antiviral
used for viral hepatitis
flu-like symtoms post-administration |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
anti-HIV
NRTI
1st drug of its kind |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
anti-HIV
Protease inhibitor
N/V/D |
|
|
Term
|
Definition
anti-HIV
Protease inhibitor
N/V/D |
|
|
Term
|
Definition
anti-HIV
Protease inhibitor
N/V/D |
|
|
Term
|
Definition
anti-HIV
Protease inhibitor
1st of its class - trials shortened due to efficacy
N/V/D |
|
|
Term
|
Definition
anti-HIV
fusion (entry) inhibitor
targets gp41 protein on HIV surface
use in HIV+ pts who have developed resistance |
|
|
Term
|
Definition
Immunosuppresant
Calcineurin inhibitor - blocks T cell activation
prevention and treatment of acute organ rejection
avoid tropical fruits and grapefruit
nephrotoxicity and renal failure possible |
|
|
Term
|
Definition
Immunosupressant
calcineurin inhibition
prophylaxis of acute rejection
avoid grapefruit
nephrotoxicity, hyperkalemia, hypomagnesemia, hyperglycemia (inhibits insulin release) |
|
|
Term
|
Definition
Immunosupressant
Antimetabolite
inactivated by hepatic xanthine oxidase
Leukopenia and thrombocytopenia
May be contraindicated in pregnancy and breast feeding (risk D)
Hepatotoxicity |
|
|
Term
Mycophenolate mofetil (CellCept) |
|
Definition
Immunosupressant
Antimetabolite
inhibits T cell and B cell proliferation
prophylactic at time of transplant
used in combo with steroids and calcineurin inhibitors
use with caution in pregnancy and lactation (risk C) |
|
|
Term
|
Definition
Immunosuppresant
Antilymphocyte - reduces number and alters function of T-lymphocytes
Major ADR: Hx of sensitivity to horse serum |
|
|
Term
|
Definition
Immunosuppresant
Antilymphocyte
horrible drug - produces anaphylactic rxns |
|
|
Term
|
Definition
Immunosuppresant
antilymphocyte
prophylaxis of acute renal rejection
have epi pen ready: hypersensitivity rxns |
|
|
Term
|
Definition
Immunosuppresant
antilymphocyte
hydrocortisone pretreatment recommended - hypersensitivity rxns |
|
|